Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
There is increasing evidence that renal replacement therapy (= continuous veno-venous hemodialysis) generates cerebral microembolism which is detectable on transcranial Doppler ultrasound.
The aim of this study is to monitor patients with transcranial Doppler under two conditions: during hemodialysis and in a hemodialysis-free interval (in each period cerebral embolic load is detected during 30 minutes).
The study hypothesis is that during hemodialysis the cerebral embolic load is significantly higher than in the hemodialysis-free interval.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patient on Hemodialysis | Renal hemodialysis |
| |
| Patient in a hemodialysis-free interval | No Renal hemodialysis |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Renal hemodialysis (Fresenius 2008K, Bad Homburg, Germany) | Device | Renal replacement therapy is frequently used in patients with renal failure in order to eliminate substances obligatory excreted by the urine. |
| Measure | Description | Time Frame |
|---|---|---|
| Quantity of cerebral embolic load | Cerebral embolic load is measured in a 30 minutes-interval during hemodialysis and in a hemodialysis-free interval. | 30 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Quality and laterality of cerebral embolic load | Quality (solid vs. gaseous) and laterality (left vs. right hemispheric dominance) of cerebral embolic load is measured in a 30 minutes-interval during hemodialysis and in a hemodialysis-free interval. | 30 minutes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The study population incloses patients who are in renal failure needing renal replacement therapy under intensive care conditions.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gabor Erdoes, MD | Medical University of Vienna | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medical University of Vienna | Vienna | 1090 | Austria |
Not provided
| ID | Term |
|---|---|
| D020766 | Intracranial Embolism |
| ID | Term |
|---|---|
| D002542 | Intracranial Embolism and Thrombosis |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000079664 | Continuous Renal Replacement Therapy |
| ID | Term |
|---|---|
| D017582 | Renal Replacement Therapy |
| D013812 | Therapeutics |
| D005112 | Extracorporeal Circulation |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D013923 | Thromboembolism |
| D016769 | Embolism and Thrombosis |